Meenakshi Aggarwal, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 22
- 4 carriers
- Office
- 1
- Since medical school
- 30 years
- Warren Alpert Medical School of Brown University, 1996
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
22 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aggarwal’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
22 of 22 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A72230 · Current
Licensed to practise in California · since 2000 · expires 2028-06-30 · Brown University Program in Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiology
- American Board of Internal Medicine - Interventional Cardiology
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$36,894
Medicare paid this office $36,894 for 401 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 142 | $8,873 | $54 |
| Return visit (30+ min) | 79 | $6,889 | $80 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $3,642 | $54 |
| New patient visit (45+ min) | 29 | $2,774 | $96 |
| Long return visit (40+ min) | 19 | $2,358 | $124 |
See all 13 services
| Short return visit (20+ min) | 142 | $8,873 | $54 |
| Return visit (30+ min) | 79 | $6,889 | $80 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $3,642 | $54 |
| New patient visit (45+ min) | 29 | $2,774 | $96 |
| Long return visit (40+ min) | 19 | $2,358 | $124 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 11 | $1,557 | $142 |
| New patient visit (30+ min) | 17 | $1,098 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 21 | $384 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 21 | $251 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $230 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 25 | $173 | $7 |
| Ultrasonic guidance for blood vessel access | 14 | $168 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $151 | $13 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
401 Original Medicare patients in 2024. Average age 73 · Under 65 12% · 85 and older 14% · Women 49% · Also on Medicaid 83% · Health risk score 2.25. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 55% · Coronary heart disease 52% · Heart failure 43% · Atrial fibrillation 35% · Chronic kidney disease 33% · Depression 21% · COPD 18% · Stroke 15% · Cancer 12% · Dementia 11%.
The office billed $425,640, Medicare allowed $50,747 and paid $36,894; for 540 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 401 | 540 | 73 | 2.25 | $425,640 | $36,894 |
| 2023 | 541 | 775 | 73 | 2.14 | $559,494 | $52,958 |
| 2022 | 378 | 514 | 73 | 1.92 | $352,060 | $37,922 |
| 2021 | 322 | 439 | 72 | 2.12 | $244,964 | $20,772 |
| 2020 | 453 | 618 | 71 | 2.45 | $278,426 | $21,473 |
| 2019 | 843 | 1,207 | 72 | 2.21 | $685,151 | $47,193 |
| 2018 | 541 | 690 | 71 | 2.17 | $452,766 | $25,678 |
| 2017 | 283 | 367 | 70 | 2.31 | $366,861 | $19,506 |
| 2015 | 47 | 49 | 70 | 2.94 | $55,569 | $5,847 |
| 2014 | 205 | 280 | 70 | 1.65 | $261,020 | $30,526 |
| 2013 | 180 | 230 | 71 | 1.92 | $177,393 | $23,190 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Short return visit (20+ min) | 206 | $13,526 | $53 |
| Return visit (30+ min) | 121 | $10,475 | $76 |
| Long return visit (40+ min) | 50 | $6,383 | $128 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $4,528 | $206 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 64 | $3,562 | $55 |
| New patient visit (45+ min) | 18 | $2,209 | $123 |
| New patient visit (30+ min) | 28 | $1,969 | $70 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,081 | $77 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 50 | $367 | $7 |
| Ultrasonic guidance for blood vessel access | 21 | $262 | $12 |
2022: 9 services
| Return visit (30+ min) | 143 | $13,722 | $86 |
| Long return visit (40+ min) | 35 | $4,697 | $130 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 21 | $4,369 | $208 |
| Short return visit (20+ min) | 64 | $4,091 | $58 |
| Telephone medical discussion with physician, 21-30 minutes | 49 | $4,066 | $78 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,239 | $56 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $465 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 52 | $404 | $7 |
| Ultrasonic guidance for blood vessel access | 16 | $200 | $12 |
2021: 10 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 17 | $3,697 | $217 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $3,318 | $302 |
| Return visit (30+ min) | 25 | $2,276 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 164 | $1,334 | $7 |
| Telephone medical discussion with physician, 5-10 minutes | 24 | $898 | $31 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $498 | $42 |
| Ultrasonic guidance for blood vessel access | 23 | $303 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $295 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $205 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 31 | $178 | $6 |
2020: 8 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $4,621 | $210 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 276 | $2,469 | $7 |
| Return visit (30+ min) | 36 | $1,350 | $35 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $906 | $38 |
| Telephone medical discussion with physician, 5-10 minutes | 33 | $652 | $19 |
| Ultrasonic guidance for blood vessel access | 22 | $294 | $13 |
| Short return visit (20+ min) | 21 | $190 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 31 | $151 | $5 |
2019: 9 services
| Short return visit (20+ min) | 260 | $13,178 | $40 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 35 | $7,968 | $228 |
| Return visit (30+ min) | 76 | $5,476 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 59 | $3,462 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 383 | $3,439 | $7 |
| Short return visit | 43 | $928 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 93 | $589 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $225 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $151 | $11 |
2018: 8 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $5,521 | $230 |
| Return visit (30+ min) | 50 | $3,293 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 355 | $3,051 | $7 |
| Short return visit (20+ min) | 41 | $1,882 | $45 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 36 | $1,852 | $51 |
| Long return visit (40+ min) | 11 | $1,097 | $100 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 11 | $294 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 36 | $228 | $6 |
2017: 6 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $4,243 | $223 |
| Return visit (30+ min) | 50 | $3,739 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 29 | $1,595 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 144 | $1,237 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 24 | $461 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 23 | $296 | $13 |
2015: 1 service
| Return visit (30+ min) | 22 | $900 | $39 |
2014: 4 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $5,616 | $244 |
| Return visit (30+ min) | 62 | $5,550 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 81 | $4,063 | $50 |
| Short return visit (20+ min) | 16 | $546 | $32 |
2013: 7 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 21 | $4,927 | $235 |
| Return visit (30+ min) | 34 | $2,706 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 45 | $2,477 | $55 |
| Long return visit (40+ min) | 19 | $1,816 | $83 |
| New patient visit (45+ min) | 11 | $1,013 | $92 |
| Ultrasound of heart | 27 | $899 | $33 |
| Short return visit (20+ min) | 21 | $751 | $36 |
Medicaid work
$10,962 in 2024
Medicaid paid $10,962 for 2,987 billed services this clinician did in 2024, up to 73 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 514 | $5,165 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 156 | $2,779 |
| Return visit (30+ min) | 185 | $2,266 |
| CARDIOVASCULAR STRESS TEST | 71 | $385 |
| CARDIOVASCULAR STRESS TEST | 71 | $246 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 41 | $122 |
| Pain severity quantified; no pain present (COA) (ONC) | 41 | $0 |
| Medication list documented in medical record (COA) | 400 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 181 | $0 |
| MOST RECENT LDL-C <100 MG/DL | 12 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 347 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 132 | $0 |
| 2024 | 2,987 | 16 | 73 | $10,962 |
| 2023 | 2,042 | 14 | 85 | $10,688 |
| 2022 | 789 | 7 | 53 | $7,606 |
| 2021 | 858 | 3 | 71 | $4,530 |
| 2020 | 1,096 | 4 | 76 | $5,835 |
| 2019 | 1,808 | 6 | 132 | $8,988 |
| 2018 | 1,130 | 4 | 105 | $4,556 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 757 | $4,173 |
| Return visit (30+ min) | 425 | $3,001 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 146 | $1,871 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 191 | $793 |
| Long return visit (40+ min) | 44 | $656 |
| CARDIOVASCULAR STRESS TEST | 14 | $120 |
| CARDIOVASCULAR STRESS TEST | 14 | $74 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 73 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 106 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 25 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 39 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 162 | $0 |
2022
| Return visit (30+ min) | 328 | $3,230 |
| Short return visit (20+ min) | 224 | $1,813 |
| Long return visit (40+ min) | 61 | $1,466 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 135 | $590 |
| CARDIOVASCULAR STRESS TEST | 13 | $237 |
| CARDIOVASCULAR STRESS TEST | 13 | $149 |
| Short return visit | 15 | $121 |
2021
| Return visit (30+ min) | 200 | $2,207 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 550 | $2,010 |
| Short return visit (20+ min) | 108 | $313 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 797 | $3,781 |
| Short return visit (20+ min) | 214 | $1,091 |
| Return visit (30+ min) | 73 | $754 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 12 | $209 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,045 | $3,682 |
| Short return visit (20+ min) | 555 | $2,152 |
| Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed | 13 | $1,379 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 83 | $1,287 |
| Return visit (30+ min) | 71 | $329 |
| Short return visit | 41 | $160 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 959 | $2,964 |
| Return visit (30+ min) | 86 | $699 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 33 | $638 |
| Short return visit (20+ min) | 52 | $254 |
Drugs they prescribed that Part D paid
$52,921
Pharmacies billed $52,921 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 339) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
286 generic and 53 brand-name prescriptions · $52,921 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 13 | $15,675 | $1,206 |
| Entresto | 16 | $13,563 | $848 |
| Amiodarone | 14 | $582 | $42 |
| Metoprolol | 35 | $498 | $14 |
| Atorvastatin | 39 | $336 | $9 |
See all 13 drugs
| Eliquis | 13 | $15,675 | $1,206 |
| Entresto | 16 | $13,563 | $848 |
| Amiodarone | 14 | $582 | $42 |
| Metoprolol | 35 | $498 | $14 |
| Atorvastatin | 39 | $336 | $9 |
| Isosorbide Mononitrate Er | 23 | $179 | $8 |
| Digoxin | 14 | $115 | $8 |
| Metoprolol | 14 | $111 | $8 |
| Losartan | 20 | $108 | $5 |
| Furosemide | 20 | $55 | $3 |
| Spironolactone | 11 | $54 | $5 |
| Amlodipine Besylate | 12 | $38 | $3 |
| Lisinopril | 12 | $24 | $2 |
Year by year
| 2024 | 339 | 93 | 0% (0) | 16% | $52,921 |
| 2023 | 295 | 85 | 0% (0) | 15% | $49,232 |
| 2022 | 350 | 75 | 0% (0) | 19% | $73,591 |
| 2021 | 298 | 75 | 0% (0) | 23% | $58,934 |
| 2020 | 271 | 68 | None | 27% | $45,077 |
| 2019 | 235 | 65 | 0% (0) | 19% | $25,987 |
| 2018 | 295 | 58 | 0% (0) | None | $20,909 |
| 2017 | 420 | 79 | None | 14% | $27,260 |
| 2016 | 440 | 80 | None | None | $32,701 |
| 2015 | 421 | 71 | None | None | $13,590 |
| 2014 | 493 | 81 | None | None | $16,621 |
| 2013 | 308 | 68 | 6% (19) | 17% | $17,046 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Entresto | 11 | $11,331 | $1,030 |
| Atorvastatin | 47 | $927 | $20 |
| Metoprolol | 23 | $864 | $38 |
| Isosorbide Mononitrate Er | 25 | $775 | $31 |
| Losartan | 21 | $345 | $16 |
2022: 10 drugs
| Eliquis | 25 | $26,067 | $1,043 |
| Xarelto | 15 | $22,318 | $1,488 |
| Isosorbide Dinitrate | 18 | $1,000 | $56 |
| Atorvastatin | 53 | $751 | $14 |
| Metoprolol | 22 | $743 | $34 |
| Isosorbide Mononitrate Er | 25 | $610 | $24 |
| Losartan | 16 | $484 | $30 |
| Furosemide | 30 | $283 | $9 |
| Clopidogrel | 13 | $247 | $19 |
| Metoprolol | 12 | $247 | $21 |
2021: 9 drugs
| Xarelto | 23 | $31,461 | $1,368 |
| Eliquis | 17 | $19,224 | $1,131 |
| Metoprolol | 30 | $817 | $27 |
| Atorvastatin | 36 | $607 | $17 |
| Furosemide | 27 | $398 | $15 |
| Isosorbide Mononitrate Er | 13 | $313 | $24 |
| Pravastatin | 11 | $202 | $18 |
| Metoprolol | 17 | $197 | $12 |
| Lisinopril | 15 | $69 | $5 |
2020: 9 drugs
| Xarelto | 25 | $27,892 | $1,116 |
| Furosemide | 27 | $359 | $13 |
| Metoprolol | 15 | $340 | $23 |
| Isosorbide Mononitrate Er | 17 | $322 | $19 |
| Atorvastatin | 21 | $278 | $13 |
| Metoprolol | 17 | $178 | $10 |
| Carvedilol | 17 | $173 | $10 |
| Clopidogrel | 13 | $141 | $11 |
| Lisinopril | 14 | $82 | $6 |
2019: 8 drugs
| Xarelto | 18 | $16,465 | $915 |
| Isosorbide Mononitrate Er | 18 | $532 | $30 |
| Atorvastatin | 34 | $429 | $13 |
| Metoprolol | 16 | $323 | $20 |
| Carvedilol | 17 | $231 | $14 |
| Losartan | 16 | $152 | $9 |
| Furosemide | 15 | $143 | $10 |
| Lisinopril | 14 | $76 | $5 |
2018: 10 drugs
| Isosorbide Mononitrate Er | 29 | $625 | $22 |
| Atorvastatin | 34 | $569 | $17 |
| Losartan | 11 | $217 | $20 |
| Metoprolol | 12 | $142 | $12 |
| Clopidogrel | 12 | $133 | $11 |
| Carvedilol | 13 | $106 | $8 |
| Hydrochlorothiazide | 18 | $102 | $6 |
| Lisinopril | 18 | $89 | $5 |
| Furosemide | 16 | $88 | $5 |
| Amlodipine Besylate | 11 | $77 | $7 |
2017: 16 drugs
| Humulin 70/30 Kwikpen | 14 | $7,447 | $532 |
| Atorvastatin | 32 | $679 | $21 |
| Isosorbide Mononitrate Er | 27 | $639 | $24 |
| Gabapentin | 14 | $381 | $27 |
| Levothyroxine | 17 | $304 | $18 |
| Valsartan | 12 | $226 | $19 |
| Carvedilol | 31 | $214 | $7 |
| Metoprolol | 16 | $195 | $12 |
| Alendronate | 16 | $173 | $11 |
| Sertraline | 13 | $138 | $11 |
| Metoprolol | 11 | $134 | $12 |
| Clopidogrel | 14 | $132 | $9 |
| Simvastatin | 14 | $132 | $9 |
| Lisinopril | 16 | $126 | $8 |
| Amlodipine Besylate | 14 | $107 | $8 |
| Hydrochlorothiazide | 11 | $58 | $5 |
2016: 14 drugs
| Isosorbide Dinitrate | 16 | $1,875 | $117 |
| Isosorbide Mononitrate Er | 31 | $871 | $28 |
| Atorvastatin | 30 | $502 | $17 |
| Clopidogrel | 42 | $393 | $9 |
| Valsartan | 12 | $293 | $24 |
| Gabapentin | 12 | $274 | $23 |
| Levothyroxine | 14 | $270 | $19 |
| Metoprolol | 26 | $231 | $9 |
| Fosinopril | 12 | $212 | $18 |
| Simvastatin | 20 | $197 | $10 |
| Sertraline | 12 | $144 | $12 |
| Amlodipine Besylate | 22 | $117 | $5 |
| Furosemide | 21 | $97 | $5 |
| Lisinopril | 16 | $75 | $5 |
2015: 16 drugs
| Zetia | 12 | $3,831 | $319 |
| Isosorbide Dinitrate | 13 | $1,887 | $145 |
| Amiodarone | 12 | $1,002 | $83 |
| Isosorbide Mononitrate Er | 25 | $647 | $26 |
| Atorvastatin | 31 | $583 | $19 |
| Valsartan | 12 | $490 | $41 |
| Clopidogrel | 38 | $458 | $12 |
| Furosemide | 48 | $189 | $4 |
| Carvedilol | 19 | $166 | $9 |
| Losartan | 17 | $165 | $10 |
| Metoprolol | 35 | $163 | $5 |
| Levothyroxine | 11 | $155 | $14 |
| Lisinopril | 14 | $111 | $8 |
| Amlodipine Besylate | 20 | $108 | $5 |
| Simvastatin | 15 | $105 | $7 |
| Spironolactone | 11 | $72 | $7 |
2014: 13 drugs
| Isosorbide Dinitrate | 15 | $3,283 | $219 |
| Potassium Chloride | 29 | $660 | $23 |
| Atorvastatin | 27 | $616 | $23 |
| Pravastatin | 22 | $596 | $27 |
| Clopidogrel | 42 | $590 | $14 |
| Isosorbide Mononitrate Er | 14 | $535 | $38 |
| Amlodipine Besylate | 34 | $399 | $12 |
| Losartan | 34 | $366 | $11 |
| Metoprolol | 15 | $349 | $23 |
| Furosemide | 31 | $237 | $8 |
| Fosinopril | 12 | $216 | $18 |
| Carvedilol | 19 | $196 | $10 |
| Metoprolol | 21 | $151 | $7 |
2013: 8 drugs
| Isosorbide Dinitrate | 17 | $3,287 | $193 |
| Clopidogrel | 20 | $2,310 | $115 |
| Atorvastatin | 18 | $779 | $43 |
| Amlodipine Besylate | 17 | $385 | $23 |
| Pravastatin | 12 | $317 | $26 |
| Oxycodone | 18 | $150 | $8 |
| Metoprolol | 14 | $134 | $10 |
| Levothyroxine | 11 | $119 | $11 |
Money from drug and device companies
$60 in 2024
| 2024 | 2 | 2 | None | $60 |
| 2023 | 1 | 1 | None | $19 |
| 2020 | 3 | 5 | None | $153 |
| 2019 | 5 | 8 | None | $121 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| iRhythm Technologies | Zio Xt Patch | $39 | 1 payment
|
| Lilly USA | Jardiance | $21 | 1 payment
|
See all 2 published payments
| Lilly USA | Meals · 2024-05-13 | Jardiance | $21 |
| iRhythm Technologies | Meals · 2024-02-06 | Zio Xt Patch | $39 |
See earlier years (2023, 2020, 2019)
2023: $19
| Abiomed | Impella | $19 | 1 payment
|
2020: $153
| Terumo Medical | Optitorque | $117 | 3 payments
|
| AbbVie | Rinvoq | $22 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $15 | 1 payment
|
2019: $121
| AbbVie | Humira | $47 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $33 | 2 payments
|
| Pfizer | Chantix | $15 | 1 payment
|
| GlaxoSmithKline | Anoro | $14 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $11 | 2 payments
|
Professional record
- NPI
- 1669560249
- Licence
- CA A72230California A72230: Current · expires 2028-06-30
- Trained
- Warren Alpert Medical School of Brown University, 1996 · 30 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A722300
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- Po Box 5280, Patient Business Services, San Jose, CA, 95150
- NPI first listed
- 2006-10-10
- NPI last updated
- 2010-01-12
This is when the NPI record was last certified, not a medical board exam.